An edition of A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries (2000)

A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries

by

Cover of: A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries by United States. Congress. House, United States. Congress. House
Read Listen

My Reading Lists:

Create a new list

Check-In

×Close
Add an optional check-in date. Check-in dates are used to track yearly reading goals.
Today
Notes
Notes

Download Options

Check nearby libraries

Buy this book

Last edited by MARC Bot
August 27, 2021 | History
Edit
An edition of A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries (2000)

A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries

by

This edition doesn't have a description yet. Can you add one?

Publish Date
Publisher
U.S. G.P.O.
Language
English

Check nearby libraries

Buy this book

Previews available in: English

Subjects

Drugs, Research, Law and legislation, Pharmaceutical industry, Taxation, International business enterprises, Research and development tax credit, Prescription pricing

Places

United States
Edition Availability
Cover of: A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries
A bill to amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries
2000, U.S. G.P.O.
in English

Add another edition?

Book Details

Edition Notes

Caption title.

Introduced Feb. 15, 2000; referred to the Committee on Ways and Means.

Published in
Washington, D.C
Other Titles
Prescription Price Equity Act of 2000., 106th Congress, 2d Session, H.R. 3665 in the House of Representatives., To amend the Internal Revenue Code of 1986 to deny tax benefits for research conducted by pharmaceutical companies where United States consumers pay higher prices for the products of that research than consumers in certain other countries.

The Physical Object

Pagination
5 p.

ID Numbers

Open Library
OL33115228M
Internet Archive
billtoamendinter00unit_51
OCLC/WorldCat
824456233

Source records

Internet Archive item record

Community Reviews (0)

Feedback?
No community reviews have been submitted for this work.

Lists

This work does not appear on any lists.

History

Download catalog record: RDF / JSON
August 27, 2021 Created by MARC Bot import new book